Menu

Image of the Day: Colorful Colonoids

Organoids grown from a mouse’s colon will be used to screen drugs for colorectal cancer.

Apr 18, 2019
Chia-Yi Hou
Mouse-derived colonoids, which are organoids grown from the colon, with actin phalloidin stained red and DNA stained turquoise. Scale bar is 50 μm.
VIOLA LOBERT

In an effort to develop a laboratory tool to study tumor suppressors in colorectal cancer, Viola Lobert of Oslo University Hospital and her team have successfully created organoids grown from the colon of a mouse.

“Organoids are suited for high-throughput screening due to their small size, and importantly can be grown from patient biopsies,” Lobert says in an email to The Scientist. “Perhaps the most exciting aspect is that testing compounds on patient-derived organoids predicts patient response, avoiding the need for xenografts.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Rapid Adoption of Carterra’s LSA™ Instrument Drives European Expansion
Rapid Adoption of Carterra’s LSA™ Instrument Drives European Expansion
Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center (CEC) and office in Munich, Germany.
Microfluidics with a pharma focus<
Microfluidics with a pharma focus<
Microfluidics has rapidly grown in popularity in recent years, and new applications for the technology continue to be reported.
An In-Depth Introduction to Hybridoma-Based Antibody Development
An In-Depth Introduction to Hybridoma-Based Antibody Development
This white paper from GenScript introduces the process of creating hybridomas and using them for monoclonal antibody production.